New Approaches to Immunotherapy for Metastatic Castration-Resistant Prostate Cancer

被引:0
|
作者
Subudhi, Sumit K. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Div Canc Med, Houston, TX 77030 USA
关键词
MISMATCH-REPAIR;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:283 / 286
页数:4
相关论文
共 50 条
  • [31] Effective combinatorial immunotherapy for castration-resistant prostate cancer
    Xin Lu
    James W. Horner
    Erin Paul
    Xiaoying Shang
    Patricia Troncoso
    Pingna Deng
    Shan Jiang
    Qing Chang
    Denise J. Spring
    Padmanee Sharma
    John A. Zebala
    Dean Y. Maeda
    Y. Alan Wang
    Ronald A. DePinho
    Nature, 2017, 543 : 728 - 732
  • [32] Autologous cellular immunotherapy for castration-resistant prostate cancer
    Almubarak, Mohammed
    Abraham, Jame
    IMMUNOTHERAPY, 2012, 4 (05) : 474 - 474
  • [33] Role of Immunotherapy in Castration-Resistant Prostate Cancer (CRPC)
    Suarez, Cristina
    Morales-Barrera, Rafael
    Ramos, Victor
    Nunez, Isaac
    Valverde, Claudia
    Planas, Jacques
    Morote, Juan
    Maldonado, Xavier
    Carles, Joan
    BJU INTERNATIONAL, 2014, 113 (03) : 367 - 375
  • [34] New insights for drug resistance in metastatic castration-resistant prostate cancer
    Kushwaha, Prem Prakash
    Gupta, Sanjay
    CANCER DRUG RESISTANCE, 2022, 5 (03) : 846 - 849
  • [35] New treatment options for patients with metastatic castration-resistant prostate cancer
    Higano, Celestia S.
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 340 - 345
  • [36] Sequential therapy of metastatic castration-resistant prostate cancer: new possibilities
    Markova, A. S.
    Matveev, V. B.
    Nazranov, B. M.
    ONKOUROLOGIYA, 2018, 14 (03): : 120 - 127
  • [37] Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
    Peter F. Mulders
    Maria De Santis
    Thomas Powles
    Karim Fizazi
    Cancer Immunology, Immunotherapy, 2015, 64 : 655 - 663
  • [38] Role of chemotherapy in castration-resistant prostate cancer. Are there new approaches?
    De Santis, M.
    Bachner, M.
    UROLOGE, 2012, 51 (01): : 39 - 43
  • [39] Immunotherapy combinations for metastatic castration-resistant prostate cancer - failed trials and future aspects
    Slovin, Susan F.
    CURRENT OPINION IN UROLOGY, 2023, 33 (05) : 390 - 395
  • [40] Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
    Mulders, Peter F.
    De Santis, Maria
    Powles, Thomas
    Fizazi, Karim
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (06) : 655 - 663